SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-257805
Filing Date
2018-08-24
Accepted
2018-08-24 17:24:58
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d606254ds3.htm S-3 420191
2 EX-4.8 d606254dex48.htm EX-4.8 331320
3 EX-4.9 d606254dex49.htm EX-4.9 335039
4 EX-5.1 d606254dex51.htm EX-5.1 41946
5 EX-23.1 d606254dex231.htm EX-23.1 1693
6 GRAPHIC g606254dsp031.jpg GRAPHIC 24571
7 GRAPHIC g606254g29x95.jpg GRAPHIC 5827
  Complete submission text file 0001193125-18-257805.txt   1173419
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-227019 | Film No.: 181037739
SIC: 2834 Pharmaceutical Preparations